In glioblastoma, breast cancer and pancreatic cancer, hnRNP A2B1 acts as an oncogene by regulating the splicing of apoptosis-associated genes to inhibit apoptosis of cancer cells [37, 38]. This evidence concerns the gene HNRNPA2B1 and pancreatic neoplasm.